RGACX | RGRYX | RGACX / RGRYX | |
Total Expense Ratio | 0.94 | 0.83 | 113% |
Annual Report Gross Expense Ratio | 0.94 | 0.98 | 96% |
Fund Existence | 23 years | 18 years | - |
Gain YTD | 15.516 | 11.671 | 133% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 332B | 364M | 91,209% |
Annual Yield % from dividends | 0.07 | 0.00 | - |
Returns for 1 year | 17.83 | 17.93 | 99% |
Returns for 3 years | 58.53 | 83.04 | 70% |
Returns for 5 years | 40.02 | 52.31 | 77% |
Returns for 10 years | 95.93 | 102.66 | 93% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNNX | 70.40 | 0.55 | +0.79% |
Janus Henderson Global Life Sciences N | |||
OSVCX | 17.90 | 0.05 | +0.28% |
JPMorgan Small Cap Value C | |||
CICAX | 65.58 | 0.08 | +0.12% |
American Funds Invmt Co of Amer 529A | |||
WCEIX | 11.27 | N/A | N/A |
Virtus Westchester Event-Driven Fd I | |||
FSRBX | 34.41 | -0.41 | -1.18% |
Fidelity Select Banking |